Regulus Therapeutics
Stock Forecast, Prediction & Price Target

Regulus Therapeutics Financial Estimates

Regulus Therapeutics Revenue Estimates

Regulus Therapeutics EBITDA Estimates

Regulus Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $44.16M
Low: $44.16M
High: $44.16M
avg. 0%
Avg: $176.76M
Low: $176.76M
High: $176.76M
avg. 300.19%
Avg: $332.6M
Low: $332.6M
High: $332.6M
avg. 88.16%
Net Income
 
% change YoY
$-27.80M
 
N/A
$-28.32M
 
-1.85%
$-30.03M
 
-6.05%
Avg: $-48.90M
Low: $-15.35M
High: $-13.65M
avg. -62.82%
Avg: $-58.85M
Low: $-17.25M
High: $-12.89M
avg. -20.33%
Avg: $6.12M
Low: $6.12M
High: $6.12M
avg. 110.40%
Avg: $35.64M
Low: $35.64M
High: $35.64M
avg. 482.13%
EBITDA
 
% change YoY
$-27.81M
 
N/A
$-28.23M
 
-1.52%
$-30.88M
 
-9.35%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $8.83M
Low: $8.83M
High: $8.83M
avg. 0%
Avg: $35.35M
Low: $35.35M
High: $35.35M
avg. 300.19%
Avg: $66.51M
Low: $66.51M
High: $66.51M
avg. 88.16%
EPS
 
% change YoY
-$3.24
 
N/A
-$1.86
 
42.59%
-$1.58
 
15.05%
Avg: -$0.77
Low: -$0.81
High: -$0.72
avg. 51.58%
Avg: -$0.8
Low: -$0.91
High: -$0.68
avg. -3.92%
Avg: $0.32
Low: $0.32
High: $0.32
avg. 140.62%
Avg: $1.88
Low: $1.88
High: $1.88
avg. 482.13%
Operating Expenses
 
% change YoY
$27.81M
 
N/A
$28.23M
 
1.52%
$9.95M
 
-64.74%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $48.91M
Low: $48.91M
High: $48.91M
avg. 0%
Avg: $195.75M
Low: $195.75M
High: $195.75M
avg. 300.19%
Avg: $368.34M
Low: $368.34M
High: $368.34M
avg. 88.16%

FAQ

What is Regulus Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 127.34% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -15.35M, average is -48.90M and high is -13.65M.

What is Regulus Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 97.09% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Regulus Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 167.60% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.81, average is -$0.77 and high is $-0.72.